Join
Live feed
·
PRReleasevia Quantisnow
Ionis Pharmaceuticals Inc. logo
Royalty Pharma plc logo

Ionis and Royalty Pharma enter into royalty agreement for up to $1.1 billion to further advance Ionis' genetic medicines and commercial readiness

ByQuantisnow·Wall Street's wire, on your screen.
IONS· Ionis Pharmaceuticals Inc.RPRX· Royalty Pharma plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IONS (Ionis Pharmaceuticals Inc.), RPRX (Royalty Pharma plc) and more on Quantisnow.